Quiero saber acerca de...

12034

Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices Controlled substance
Drug code
AH7921 3,4-dichloro-N-1-dimethylaminocyclohexylmethylbenzamide
Acetylmethadol
Alphamethadol
Ketobemidone
Noracymethadol
Para-Fluorofentanyl
3-Methylfentanyl
Alpha-methylfentanyl
Acetyl Fentanyl N-1-phenethylpiperidin-4-yl-N-phenylacetamide
2-methoxy-N-1-phenethylpiperidin-4-yl-N-phenylacetamide
3-Methylthiofentanyl
Cyclopropyl Fentanyl
Fentanyl related-compounds as defined in 21 CFR 1308.11&h
Amphetamine
Methamphetamine
Methylphenidate
Amobarbital
Pentobarbital
Secobarbital
Phencyclidine
Cocaine
Codeine
Dihydrocodeine
Oxycodone
Hydromorphone
Ecgonine
Hydrocodone
Levorphanol
Meperidine
Meperidine intermediate-B
Methadone
Dextropropoxyphene, bulk non-dosage forms
Morphine
Thebaine
Levo-alphacetylmethadol
Oxymorphone
Carfentanil
Tapentadol
Fentanyl

The company plans to import the listed controlled substances for feasibility studies for new products and cross reactivity studies for existing products. The products will serve as raw materials for In Vitro Diagnostic quantitative assay. No other activity for these drug codes is authorized for this registration.
Approval of permit applications will occur only when the registrants business activity is consistent with what is authorized under 21 U.S.C. 952a2.
Authorization will not extend to the import of the Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale.
William T. McDermott, Assistant Administrator.
FR Doc. 202104147 Filed 22621; 8:45 am BILLING CODE P

VerDate Sep<11>2014

18:48 Feb 26, 2021

Jkt 253001

9551
9601
9605
9628
9633
9812
9813
9814
9821
9825
9833
9845
9850
1100
1105
1724
2125
2270
2315
7471
9041
9050
9120
9143
9150
9180
9193
9220
9230
9233
9250
9273
9300
9333
9648
9652
9743
9780
9801

Schedule I
I I
I I
I I
I I
I I
I I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II

Drug Enforcement Administration
comments on or objections to the issuance of the proposed registration on or before April 30, 2021.

Docket No. DEA781

ADDRESSES:

DEPARTMENT OF JUSTICE

Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Cosmic Light LLC
Drug Enforcement Administration, Justice.
ACTION: Notice of application.
AGENCY:

The Drug Enforcement Administration DEA is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic classes of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA
registration.
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written SUMMARY:

PO 00000

Frm 00116

Fmt 4703

Sfmt 4703

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No DEAXXX in all correspondence, including attachments.
The Controlled Substances Act CSA
prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33a, DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections of the requested registration, as
SUPPLEMENTARY INFORMATION:

E:FRFM01MRN1.SGM

01MRN1